http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105102445-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
filingDate 2014-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fc65e55e9aaa25a773e5aaa832e3e64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca0166f0b310944b7ade7a0e0ab64699
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5da5dea38a5b59e4f438b848a75314c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff1862b3e4d14d5df2937cd435b8c727
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5df9d7e996793a85d4a746fdaa693d97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94c6ab36d257fa3c4de91d7c1a283610
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08aa9a0ba83c3b64e64d5fb66a7eaaad
publicationDate 2015-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105102445-A
titleOfInvention Novel dihydroquinolin-2-one derivatives as aldosterone synthase (CYP11B2 or CYP11B1) inhibitors
abstract The present invention provides novel compounds having general formula (I), compositions comprising said compounds and methods of using said compounds, wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 9 , R 10 , R 11 and A are as described herein. Compounds of formula (I) are useful as aldosterone synthase (CYP11B2 or CYP11B1 ) inhibitors for the treatment of various disorders.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105073732-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9593107-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105073732-B
priorityDate 2013-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011112067-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-85100796-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012148808-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420280859
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72208233
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431528496
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90391190

Total number of triples: 36.